Evaluation of different knee cooling devices to control pain after knee replacement surgery
| ISRCTN | ISRCTN17454353 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN17454353 |
| IRAS number | 322564 |
| Secondary identifying numbers | CPMS 55347, IRAS 322564 |
- Submission date
- 14/07/2023
- Registration date
- 08/05/2024
- Last edited
- 04/04/2025
- Recruitment status
- Recruiting
- Overall study status
- Ongoing
- Condition category
- Musculoskeletal Diseases
Plain English summary of protocol
Background and study aims
Medial osteoarthritis – wearing of the inside of the knee joint – can be treated with knee replacement procedures, where either part or the whole of the knee joint is replaced. For all major knee operations, post-surgery the site of operation can be painful. Increased pain may limit a patient’s progress with post-operative mobilisation. Therefore, research is already ongoing in the field of knee surgery to determine if different type of bandaging and cooling of the affected leg post-surgery may improve patient and clinical outcomes. A relatively new method is now available which involves a combination of active compression and cooling, rather than passive compression and cooling. This may reduce pain. This present study aims to assess if active compression and cooling is better than standard passive compression and cooling in terms of keeping a patient comfortable by reducing pain and possibly improving other clinical outcomes too.
Who can participate?
Patients aged 18 years or older, listed for knee arthroplasty (replacement) surgery, who in the opinion of the treating surgeon, that compression & cooling therapy may be of benefit.
What does the study involve?
This study involves a comparative evaluation of two different types of cooling therapy that is applied to the knee joint of patient who have just undergone a knee replacement operation. Straight after surgery, patients will receive either a standard cooling sleeve (cryo/cuff) or a cooling brace that also compresses (VPULSE); the latter is designed to both cool the joint and stimulate blood flow with the intermittent compression action. Pain levels are measured at various intervals and compared for the two different cooling device interventions. Other parts of the knee surgery and recovery management of patients is left unchanged.
What are the possible benefits and risks of participating?
It may be the case that one type of cooling therapy, either standard or with added intermittent compression, gives a patient more pain relief than the other. No additional risks are anticipated for patients. Both devices are approved for this intended use and measures are in place to avoid too much cooling or too much compression.
Where is the study run from?
North Cumbria Integrated Care NHS Foundation Trust (UK)
When is the study starting and how long is it expected to run for?
March 2023 to September 2026
Who is funding the study?
Joint Operations Ltd (UK)
Who is the main contact?
Dr Leon Jonker, Leon.jonker@ncic.nhs.uk
Contact information
Scientific
R&D Department
North Cumbria Integrated Care NHS Foundation Trust
Penrith
CA11 8HX
United Kingdom
 ORCID ID |
0000-0001-5867-4663 |
|---|---|
| Phone | +44 1768 245975 |
| Leon.jonker@ncic.nhs.uk |
Study information
| Study design | Interventional randomized controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Hospital |
| Study type | Treatment |
| Participant information sheet | 43952 ALASKA PIS v2.0 23Jun2023.pdf |
| Scientific title | ALASKA trial, A single-centre, two-arm, controlled, prospective randomized trial comparing AIRCAST® KNEE CRYO/CUFF™ passive compressive cryotherapy with VPULSE® active compressive cryotherapy after knee arthroplasty surgery |
| Study acronym | ALASKA trial |
| Study objectives | The main objective of the study is whether VPULSE® is significantly better than standard AIRCAST® KNEE CRYO/CUFF™ for pain control post-surgery when measured on a visual display pain scale. |
| Ethics approval(s) |
Approved 08/03/2023, London - City & East Research Ethics Committee (Bristol Research Ethics Committee Centre, Whitefriars, Level 3, Block B, Lewins Mead, Bristol, BS1 2NT, United Kingdom; +44 207 104 8124; cityandeast.rec@hra.nhs.uk), ref: 23/LO/0186 |
| Health condition(s) or problem(s) studied | Post surgical pain management in knee replacement for osteoarthritis |
| Intervention | Control (standard care) arm - AIRCAST® KNEE CRYO/CUFF™ Once the operation is finished, a wound dressing is applied and a standard bandage is applied. It consists of one layer of soft synthetic bandage, stretching from proximal tibia to distal femur covered by a further layer of crepe bandage prior to or after tourniquet deflation, with 50% overlap of each layer. Once transferred to the ward for recovery, this standard bandage will be removed and AIRCAST® KNEE CRYO/CUFF™ cryotherapy is applied to the patient’s index knee. This is a sleeve containing iced water and it will be utilised for up to 48 hours post-operation or until patient discharge, whichever of the two is sooner. The CRYO/CUFF™ is designed to combine the therapeutic benefits of controlled cold compression to minimise hemarthrosis and swelling and reduce pain. The cuff is anatomically designed to completely fit the knee providing maximum coverage of the whole joint and allowing the whole surface area to have the continual cooling benefit of cryotherapy. The cuff is attached to the Gravity Aircast Cryo/Cuff Cooler and will hold water and ice needed for six to eight hours of cryotherapy. Intervention arm - VPULSE® Once the operation is finished, a wound dressing is applied and a standard bandage is applied. It consists of one layer of soft synthetic bandage, stretching from proximal tibia to distal femur covered by a further layer of crepe bandage prior to or after tourniquet deflation, with 50% overlap of each layer. Once transferred to the ward for recovery, this standard bandage will be removed and VPULSE compression cryotherapy is applied to the patient’s index knee. As with standard treatment arm, the VPULSE cuff is applied over the routine surgical wound dressing. The cryotherapy effect is achieved by circulating cold water using a pump rather than gravity-driven cryotherapy with the current Aircast Cryo/Cuff set up that is standard care. The VPULSE also achieves compression by intermittent dynamic compression; this is an approximate pressure of 50mmHG. Further info regarding VPULSE can be obtained from the Joint Operations website: https://www.jointoperations.co.uk/buy-online/vpulse/ |
| Intervention type | Device |
| Pharmaceutical study type(s) | Not Applicable |
| Phase | Not Applicable |
| Drug / device / biological / vaccine name(s) | AIRCAST® KNEE CRYO/CUFF™, VPULSE® |
| Primary outcome measure | 1. Pain at rest is measured using the visual display scale (VDS) at baseline at pre-surgery, and 1, 3, 5,12 days and 6 weeks post-surgery 2. Pain (walking) is measured using the visual display scale (VDS) at baseline at pre-surgery, and 1, 3, 5,12 days and 6 weeks post-surgery 3. Types of pain are measured using the McGill pain questionnaire at baseline at pre-surgery, and 1, 3, 5,12 days and 6 weeks post-surgery 4. Knee limb range of motion is measured with a goniometer at baseline at pre-surgery, and 6 weeks post-surgery 5. Knee functionality is measured with validated KOOS score at baseline at pre-surgery, and 6, 12 weeks post-surgery 6. Patient satisfaction with the allocated cooling therapy is measured at 5 days post-surgery |
| Secondary outcome measures | There are no secondary outcome measures |
| Overall study start date | 08/03/2023 |
| Completion date | 30/09/2026 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | Both |
| Target number of participants | Planned Sample Size: 88; UK Sample Size: 88 |
| Key inclusion criteria | 1. Patient who is listed for knee arthroplasty (replacement) surgery, either partial or total knee replacement (unilateral). 2. Clinical indication, in the opinion of the treating surgeon, that compression & cooling therapy may be of benefit to the patient 3. Adult patients aged > 18 years 4. Mental capacity to give written informed consent |
| Key exclusion criteria | 1. Under the age of 18 years 2. Unable to fully understand the consent process and provide informed consent due to either language barriers or mental capacity 3. Revision of previous knee replacement or osteotomy on the index leg. 4. Limited life expectancy, i.e. undergoing palliative care 5. Any condition that is associated with excessive bleeding, coagulation abnormalities or any other significant haematological condition (e.g. Factor V Leiden, haemophilia). 6. Cardiovascular or vascular condition that in the opinion of the treating surgeon contraindicates the use of compression bandaging, including moderate to severe peripheral arterial disease, venous leg ulcer, high dose anti-coagulant medication 7. Any skin or other condition that contraindicates the use of compression and cooling therapy. 8. Patients who are participating in another interventional research study involving an investigational product related to the knee procedure and its aftercare. 9. The patient has concurrent (medical) conditions that in the opinion of the investigator may compromise patient safety or study objectives. 10. Patient has practical or mobility issues which will prevent them from removing the device themselves |
| Date of first enrolment | 01/04/2023 |
| Date of final enrolment | 31/05/2026 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Carlisle
CA2 7HY
United Kingdom
Sponsor information
Hospital/treatment centre
Pillars Building
Cumberland Infirmary
Infirmary Street
Carlisle
CA2 7HY
England
United Kingdom
| Phone | +44 1228608926 |
|---|---|
| dave.dagnan@ncic.nhs.uk | |
| Website | https://www.ncic.nhs.uk/ |
"ROR" |
https://ror.org/003hq9m95 |
Funders
Funder type
Industry
No information available
Results and Publications
| Intention to publish date | 30/06/2025 |
|---|---|
| Individual participant data (IPD) Intention to share | Yes |
| IPD sharing plan summary | Published as a supplement to the results publication |
| Publication and dissemination plan | Planned publication in a high-impact peer-reviewed journal |
| IPD sharing plan | All data generated or analysed during this study will be included in the subsequent results publication |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | version 2.0 | 23/06/2023 | 14/07/2023 | No | Yes |
| Protocol file | version 2.0 | 23/06/2023 | 14/07/2023 | No | No |
| Protocol file | version 2.1 | 29/11/2024 | 04/04/2025 | No | No |
Additional files
Editorial Notes
04/04/2025: The following changes were made:
1. Protocol (not peer reviewed) version 2.1 added.
2. The recruitment end date was changed from 28/02/2024 to 31/05/2026.
3. The overall study end date was changed from 31/03/2025 to 30/09/2026.
14/07/2023: Trial's existence confirmed by the National Institute for Health and Care Research (NIHR) (UK).
